Cancer Therapy - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Cancer Therapy Market is expected to grow at a CAGR of 10.4% during the forecast period. Rising initiatives by the government for alertness of cancer and R&D initiatives by the companies are the major factors driving the market growth. However, fluctuation in reimbursement policies is restraining the market growth.
Cancer therapy is the treatment of cancer, mostly done along with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain.
Based on treatment type, the target therapy segment is likely to have a huge demand due to its specificity towards cancer cells. It involves modulators of gene expression, toxin molecules etc. By geography, North America is going to have a lucrative growth during the forecast period due to increase in adoption of this therapy in the emerging economies such as US and increasing occurrences of cancer in the country.
Some of the key players profiled in the Cancer Therapy Market include Pfizer Inc, Novartis AG, Merck & Co Inc, Johnson and Johnson, F. Hoffmann-La Roche AG, Eli Lilly and Company, Bayer AG, AstraZeneca PLC and Amgen Inc.
Cancer Types Covered:
• Respiratory/Lung Cancer
• Prostate Cancer
• Gynecologic Cancer
• Gastrointestinal Cancer
• Breast Cancer
• Blood Cancer
Treatment Types Covered:
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy
• Chemotherapy
End Users Covered:
• Cancer and Radiation Therapy Centers
• Hospitals
• Specialty Clinics
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cancer Therapy Market, By Cancer Type
5.1 Introduction
5.2 Respiratory/Lung Cancer
5.3 Prostate Cancer
5.4 Gynecologic Cancer
5.5 Gastrointestinal Cancer
5.6 Breast Cancer
5.7 Blood Cancer
6 Global Cancer Therapy Market, By Treatment Type
6.1 Introduction
6.2 Targeted Therapy
6.3 Immunotherapy
6.4 Hormonal Therapy
6.5 Chemotherapy
7 Global Cancer Therapy Market, By End User
7.1 Introduction
7.2 Cancer and Radiation Therapy Centers
7.3 Hospitals
7.4 Specialty Clinics
8 Global Cancer Therapy Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Pfizer Inc
10.2 Novartis AG
10.3 Merck & Co Inc
10.4 Johnson and Johnson
10.5 F. Hoffmann-La Roche AG
10.6 Eli Lilly and Company
10.7 Bayer AG
10.8 AstraZeneca PLC
10.9 Amgen Inc
List of Tables
1 Global Cancer Therapy Market Outlook, By Region (2017-2027) ($MN)
2 Global Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
3 Global Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
4 Global Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
5 Global Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
6 Global Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
7 Global Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
8 Global Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
9 Global Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
10 Global Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
11 Global Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
12 Global Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
13 Global Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
14 Global Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
15 Global Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
16 Global Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
17 Global Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
18 North America Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
19 North America Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
20 North America Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
21 North America Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
22 North America Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
23 North America Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
24 North America Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
25 North America Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
26 North America Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
27 North America Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
28 North America Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
29 North America Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
30 North America Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
31 North America Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
32 North America Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
33 North America Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
34 North America Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
35 Europe Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
36 Europe Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
37 Europe Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
38 Europe Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
39 Europe Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
40 Europe Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
41 Europe Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
42 Europe Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
43 Europe Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
44 Europe Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
45 Europe Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
46 Europe Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
47 Europe Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
48 Europe Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
49 Europe Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
50 Europe Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
51 Europe Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
52 Asia Pacific Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
53 Asia Pacific Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
54 Asia Pacific Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
55 Asia Pacific Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
56 Asia Pacific Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
57 Asia Pacific Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
58 Asia Pacific Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
59 Asia Pacific Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
60 Asia Pacific Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
61 Asia Pacific Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
62 Asia Pacific Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
63 Asia Pacific Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
64 Asia Pacific Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
65 Asia Pacific Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
66 Asia Pacific Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
67 Asia Pacific Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
68 Asia Pacific Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
69 South America Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
70 South America Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
71 South America Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
72 South America Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
73 South America Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
74 South America Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
75 South America Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
76 South America Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
77 South America Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
78 South America Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
79 South America Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
80 South America Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
81 South America Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
82 South America Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
83 South America Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
84 South America Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
85 South America Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
86 Middle East & Africa Cancer Therapy Market Outlook, By Country (2017-2027) ($MN)
87 Middle East & Africa Cancer Therapy Market Outlook, By Cancer Type (2017-2027) ($MN)
88 Middle East & Africa Cancer Therapy Market Outlook, By Respiratory/Lung Cancer (2017-2027) ($MN)
89 Middle East & Africa Cancer Therapy Market Outlook, By Prostate Cancer (2017-2027) ($MN)
90 Middle East & Africa Cancer Therapy Market Outlook, By Gynecologic Cancer (2017-2027) ($MN)
91 Middle East & Africa Cancer Therapy Market Outlook, By Gastrointestinal Cancer (2017-2027) ($MN)
92 Middle East & Africa Cancer Therapy Market Outlook, By Breast Cancer (2017-2027) ($MN)
93 Middle East & Africa Cancer Therapy Market Outlook, By Blood Cancer (2017-2027) ($MN)
94 Middle East & Africa Cancer Therapy Market Outlook, By Treatment Type (2017-2027) ($MN)
95 Middle East & Africa Cancer Therapy Market Outlook, By Targeted Therapy (2017-2027) ($MN)
96 Middle East & Africa Cancer Therapy Market Outlook, By Immunotherapy (2017-2027) ($MN)
97 Middle East & Africa Cancer Therapy Market Outlook, By Hormonal Therapy (2017-2027) ($MN)
98 Middle East & Africa Cancer Therapy Market Outlook, By Chemotherapy (2017-2027) ($MN)
99 Middle East & Africa Cancer Therapy Market Outlook, By End User (2017-2027) ($MN)
100 Middle East & Africa Cancer Therapy Market Outlook, By Cancer and Radiation Therapy Centers (2017-2027) ($MN)
101 Middle East & Africa Cancer Therapy Market Outlook, By Hospitals (2017-2027) ($MN)
102 Middle East & Africa Cancer Therapy Market Outlook, By Specialty Clinics (2017-2027) ($MN)
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
Select License Type
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.